[EN] NOVEL PIPERAZINYL-ARYLOXY AND PIPERAZINYL-HETEROARYLOXY-N-ARYL LACTAMS<br/>[FR] NOUVEAUX LACTAMES DE PIPERAZINYL-ARYLOXY ET DE PIPERAZINYL-HETEROARYLOXY-N-ARYLE
申请人:PFIZER PROD INC
公开号:WO2004110994A1
公开(公告)日:2004-12-23
The present invention relates to compounds of formula (I), wherein Ar, Y and G are as defined in the specification, a is 1 to 4, Z and W are carbon or nitrogen and n is 1, 2 or 3; and to pharmaceutical compositions comprising the compound of formula (I) and a pharmaceutically effective carrier; and to a method useful in treating or preventing in mammals, including humans, a disorder or condition selected from the group consisting of anxiety, depression, dysthymia, major depressive disorder, migraine, posttraumatic stress disorder, avoidant personality disorder, borderline personality disorder and phobias.
本发明涉及式(I)的化合物,其中Ar、Y和G如规范中定义,a为1至4,Z和W为碳或氮,n为1、2或3;以及包括式(I)的化合物和药学有效载体的药物组合物;以及一种用于治疗或预防哺乳动物,包括人类,中选择的焦虑、抑郁、忧郁症、重性抑郁障碍、偏头痛、创伤后应激障碍、回避性人格障碍、边缘型人格障碍和恐惧症等疾病或症状的方法。